For research purposes only. Not for human consumption.
PT-141 10mg (Bremelanotide) is a synthetic cyclic heptapeptide analogue derived from alpha-melanocyte stimulating hormone. As a non-selective melanocortin agonist with activity at MC1R, MC3R, MC4R, and MC5R, PT-141 has been used in research to investigate melanocortin receptor-mediated pathways, with particular interest in MC4R signalling in the central nervous system and its roles in autonomic regulation, appetite modulation, and limbic system activity.
Research on PT-141 has examined its activation of hypothalamic melanocortin pathways and the central coordinating mechanisms involving MC4R in physiological arousal models. Studies have also investigated MC4R interactions with neuropeptide Y and melanocortin pathways in appetite and energy homeostasis, as well as MC1R involvement in pigmentation biology. The cyclic structure of PT-141 confers greater resistance to enzymatic cleavage compared to linear melanocortin peptides, making it a useful tool for receptor binding investigations.
Supplied as a high-purity white lyophilised powder, this product exceeds >99% purity as verified by HPLC analysis. Its freeze-dried formulation ensures long-term structural stability, maintaining peptide integrity throughout storage and transport. Researchers may reconstitute the compound using bacteriostatic water or a sterile diluent suited to their experimental protocol.
PT-141 10mg is intended exclusively for in vitro and non-clinical scientific research. It is not approved for human or animal therapeutic, diagnostic, or medicinal use. All handling and experimentation must be conducted by trained professionals within appropriate controlled laboratory environments.
Disclaimer: All products supplied by Ultima Labs are intended solely for laboratory and scientific research purposes. These products are not licensed, approved, or meant for human or animal consumption, nor for any form of therapeutic, medicinal, or diagnostic use. The information presented on this website has not undergone evaluation or approval by the Therapeutic Goods Administration (TGA) or any other regulatory authority. These compounds are not formulated to diagnose, treat, cure, or prevent any disease or health condition. Purchase is limited to qualified professionals, researchers, and authorized research institutions both within Australia and internationally. By placing an order, you acknowledge and agree to comply with these terms.